IJCM  Vol.5 No.5 , March 2014
Review: Outcomes of Revascularization Strategies for Coronary Artery Disease
ABSTRACT

The optimal revascularization strategy for patients with coronary artery disease is influenced by the continuous improvement in medical therapy and the improved designs of the new generation of coronary stents allowing them to be increasingly applied in patients with complex coronary anatomy, including those with left main stem disease. On the other hand, surgical results are also improved as a result of the increased experience over years and the improvement of myocardial protection techniques. This will make the comparison of percutaneous coronary interventions and coronary artery bypass surgery a moving target. In this paper, we reviewed the recent randomized controlled trials and important registries emphasizing the benefits and the results of each therapy in different patient subsets. A heart team of both cardiologists and cardiac surgeons is of paramount importance in choosing the optimal revascularization strategy.


Cite this paper
Albacker, T. , Albackr, H. , Al Shamiri, M. and Mobeirek, A. (2014) Review: Outcomes of Revascularization Strategies for Coronary Artery Disease. International Journal of Clinical Medicine, 5, 260-274. doi: 10.4236/ijcm.2014.55040.
References
[1]   Mehta, S.R., Cannon, C.P., Fox, K.A., et al. (2005) Routine vs Selective Invasive Strategies in Patients with Acute Coronary Syndromes: A Collaborative Meta-Analysis of Randomized Trials. JAMA, 293, 2908-2917.
http://dx.doi.org/10.1001/jama.293.23.2908

[2]   Hachamovitch, R., Hayes, S.W., Friedman, J.D., Cohen, I. and Berman, D.S. (2003) Comparison of the Short-Term Survival Benefit Associated with Revascularization Compared with Medical Therapy in Patients with No Prior Coronary Artery Disease Undergoing Stress Myocardial Perfusion Single Photon Emission Computed Tomography. Circulation, 107, 2900-2907. http://dx.doi.org/10.1161/01.CIR.0000072790.23090.41

[3]   Shaw, L.J., Berman, D.S., Maron, D.J., et al. (2008) Optimal Medical Therapy with or without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy. Circulation, 117, 1283-1291.
http://dx.doi.org/10.1161/CIRCULATIONAHA.107.743963

[4]   Katritsis, D.G. and Ioannidis, J.P. (2007) PCI for Stable Coronary Disease. New England Journal of Medicine, 357, 414-415. http://dx.doi.org/10.1056/NEJMc071317

[5]   Serruys, P.W., Morice, M.C., Kappetein, A.P., Colombo, A., Holmes, D.R., Mack, M.J., Ståhle, E., Feldman, T.E., Van den Brand, M., Bass, E.J., Dyck, N.V., Leadley, K., Dawkins, K.D. and Mohr, F.W. (2009) For the SYNTAX Investigators. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. New England Journal of Medicine, 360, 961-972. http://dx.doi.org/10.1056/NEJMoa0804626

[6]   Banning, A.P., Westaby, S., Morice, M.C., Kappetein, A.P., Mohr, F.W., Berti, S., Glauber, M., Kellett, M.A., Kramer, R.S., Leadley, K., Dawkins, K.D. and Serruys, P.W. (2010) Diabetic and Nondiabetic Patients with Left Main and/or 3-Vessel Coronary Artery Disease Comparison of Outcomes with Cardiac Surgery and Paclitaxel-Eluting Stents. Journal of the American College of Cardiology, 55, 1067-1075. http://dx.doi.org/10.1016/j.jacc.2009.09.057

[7]   Kappetein, A.P., Feldman, T.E., Mack, M.J., Morice, M.C., Holmes, D.R., Stahle, E., Dawkins, K.D., Mohr, F.W., Serruys, P.W. and Colombo, A. (2011) Comparison of Coronary Bypass Surgery with Drug-Eluting Stenting for the Treatment of Left Main and/or Three-Vessel Disease: 3-Year Follow-Up of the SYNTAX Trial. European Heart Journal, 32, 2125-2134. http://dx.doi.org/10.1093/eurheartj/ehr213

[8]   The BARI Investigators (2000) Seven-Year Outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by Treatment and Diabetic Status. Journal of the American College of Cardiology, 35, 1122-1129.
http://dx.doi.org/10.1016/S0735-1097(00)00533-7

[9]   The BARI Investigators (2007) The Final 10-Year Follow-Up Results from the BARI Randomized Trial. Journal of the American College of Cardiology, 49, 1600-1606. http://dx.doi.org/10.1016/j.jacc.2006.11.048

[10]   King 3rd, S.B., Kosinski, A.S., Guyton, R.A., Lembo, N.J. and Weintraub, W.S. (2000) Eight-Year Mortality in the Emory Angioplasty versus Surgery Trial (EAST). Journal of the American College of Cardiology, 35, 1116.
http://dx.doi.org/10.1016/S0735-1097(00)00546-5

[11]   Investigators SoS (2002) Coronary Artery Bypasses Surgery versus Percutaneous Coronary Intervention with Stent Implantation in Patients with Multivessel Coronary Artery Disease (the Stent or Surgery Trial): A Randomized Controlled Trial. Lancet, 360, 965. http://dx.doi.org/10.1016/S0140-6736(02)11078-6

[12]   Abizaid, A., Costa, M.A., Centemero, M., Abizaid, A.S., Legrand, V.M., Limet, R.V., et al. (2001) Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of Multivessel Coronary Disease Patients: Insights from the Arterial Revascularization Therapy Study (ARTS) Trial. Circulation, 104, 533.
http://dx.doi.org/10.1161/hc3101.093700

[13]   Serruys, P.W., Andrew, T.L., Ong, A.L., Herwerden, L.A., Sousa, J.E., Jatene, A., Johannes, J.R.M., Bonnier, J., Jacques, P.M.A., Schönberger, J., Buller, N., Bonser, R., Disco, C., Backx, B., Hugenholtz, P.G., Firth, B.G. and Unger, F. (2005) Five-Year Outcomes after Coronary Stenting versus Bypass Surgery for the Treatment of Multivessel Disease the Final Analysis of the Arterial Revascularization Therapies Study (ARTS) Randomized Trial. Journal of the American College of Cardiology, 46, 575-581. http://dx.doi.org/10.1016/j.jacc.2004.12.082

[14]   Daemen, J., Kuck, K.H., Macaya, C., LeGrand, V., Vrolix, M., Carrie, D., Sheiban, I., Suttorp, M.J., Vranckx, P., Rademaker, T., Goedhart, D., Schuijer, M., Wittebols, K., Macours, N., Stoll, H.P. and Serruys, P.W. (2008) On Behalf of the ARTS-II Investigators. Multivessel Coronary Revascularization in Patients with and without Diabetes Mellitus 3-Year Follow-Up of the ARTS-II Trial. Journal of the American College of Cardiology, 52, 1957-1967.
http://dx.doi.org/10.1016/j.jacc.2008.09.010

[15]   Kapur, A., Hall, R.J., Malik, I.S., Qureshi, A.C., Butts, J., de Belder, M., Baumbach, A., Angelini, G., de Belder, A., Oldroyd, K.G., Flather, M., Roughton, M., Nihoyannopoulos, P., Bagger, J.P., Morgan, K. and Beatt, K.J. (2010) Randomized Comparison of Percutaneous Coronary Intervention with Coronary Artery Bypass Grafting in Diabetic Patients 1-Year Results of the CARDia (Coronary Artery Revascularization in Diabetes) Trial. Journal of the American College of Cardiology, 55, 432-440. http://dx.doi.org/10.1016/j.jacc.2009.10.014

[16]   Rodriguez, A.E., Baldi, J., Pereira, C.F., Navia, J., Alemparte, M.R., Delacasa, A., Vigo, F., Vogel, D., O’Neill, W., Palacios, I.F. and ERACI II Investigators (2005) Five-Year Follow-Up of the Argentine Randomized Trial of Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in Patients with Multiple Vessel Disease (ERACI II). Journal of the American College of Cardiology, 46, 582-588. http://dx.doi.org/10.1016/j.jacc.2004.12.081

[17]   Morrison, D.A., Sethi, G., Sacks, J., Henderson, W., Grover, F., Sedlis, S., Esposito, R., Ramanathan, K., Weiman, D., Saucedo, J., Antakli, T., Paramesh, V., Pett, S., Vernon, S., Birjiniuk, V., Welt, F., Krucoff, M., Wolfe, W., Lucke, J.C., Mediratta, S., Booth, D., Barbiere, C., Lewis, D. and Investigators of the Angina with Extremely Serious Operative Mortality Evaluation (AWESOME) (2001) Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft Surgery for Patients with Medically Refractory Myocardial Ischemia and Risk Factors for Adverse Outcomes with Bypass: A Multicenter, Randomized Trial. Journal of the American College of Cardiology, 38, 143-149.

[18]   Farkouh, M.E., Domanski, M., Sleeper, L.A., Siami, F.S., Dangas, G.M.D., Mack, M., Yang, M., Cohen, D.J., Rosenberg, Y., Solomon, S.D., Desai, A.S., Gersh, B.J., Magnuson, E.A., Lansky, A., Boineau, R., Weinberger, J., Ramanathan, K., Sousa, J.E., Rankin, J., Bhargava, B., Buse, J., Hueb, W., Smith, C.R., Muratov, V., Bansilal, S., King III, S., Bertrand, M., Fuster, V. and FREEDOM Trial Investigators (2012) Strategies for Multivessel Revascularization in Patients with Diabetes. New England Journal of Medicine, 367, 2375-2384. http://dx.doi.org/10.1056/NEJMoa1211585

[19]   Kim, Y.H., Park, D.W., Ahn, J.M., Yun, S.C., Song, H.G., Lee, J.Y., Kim, W.J., Kang, S.J., Lee, S.W., Lee, C.W., Park, S.W., Jang, Y., Jeong, M.H., Kim, H.S., Hur, S.H., Rha, S.W., Lim, D.S., Her, S.H., Seung, K.B., Seong, I.W., Park, S.J. and PRECOMBAT-2 Investigators (2012) Everolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Stenosis the PRECOMBAT-2 (Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease) Study. Journal of the American College of Cardiology, 5, 708-717. http://dx.doi.org/10.1016/j.jcin.2012.05.002

[20]   Boudriot, E., Thiele, H., Walther, T., Liebetrau, C., Boeckstegers, P., Pohl, T., Reichart, B., Mudra, H., Beier, F., Gansera, B., Neumann, F.J., Gick, M., Zietak, T., Desch, S., Schuler, G. and Mohr, F.W. (2011) Randomized Comparison of Percutaneous Coronary Intervention with Sirolimus-Eluting Stents versus Coronary Artery Bypass Grafting in Unprotected Left Main Stem Stenosis. Journal of the American College of Cardiology, 57, 538-545.
http://dx.doi.org/10.1016/j.jacc.2010.09.038

[21]   Malenka, D.J., Leavitt, B.J., Hearne, M.J., Robb, J.F., Baribeau, Y.R., Ryan, T.J., Helm, R.E., Kellett, M.A., Dauerman, H.L., Dacey, L.J., Silver, M.T., VerLee, P.N., Weldner, P.W., Hettleman, B.D., Olmstead, E.M., Piper, W.D., O’Connor, G.T. and Northern New England Cardiovascular Disease Study Group (2005) Comparing Long-Term Survival of Patients with Multivessel Coronary Disease after CABG or PCI Analysis of BARI-Like Patients in Northern New England. Circulation, 112, I-371-I-376.

[22]   Hannan, E.L., Racz, M.J., Walford, G., Jones, R.H., Ryan, T.J., Bennett, E., Culliford, A.T., Wayne Isom, O., Gold, J.P. and Rose, E.A. (2005) Long-Term Outcomes of Coronary-Artery Bypass Grafting versus Stent Implantation. New England Journal of Medicine, 352, 2174-2183. http://dx.doi.org/10.1056/NEJMoa040316

[23]   Bair, T.L., Muhlestein, J.B., May, H.T., Meredith, K.G., Horne, B.D., Pearson, R.R., Li, Q., Jensen, K.R., Anderson, J.L. and Lappe, D.L. (2007) Surgical Revascularization Is Associated with Improved Long-Term Outcomes Compared With Percutaneous Stenting in Most Subgroups of Patients with Multivessel Coronary Artery Disease: Results from the Intermountain Heart Registry. Circulation, 116, I-226-I-231.

[24]   Shiomi, H., Morimoto, T., Hayano, M., Furukawa, Y., Nakagawa, Y., Tazaki, J., Imai, M., Yamaji, K., Tada, T., Natsuaki, M., Saijo, S., Funakoshi, S., Nagao, K., Hanazawa, K., Ehara, N., Kadota, K., Iwabuchi, M., Shizuta, S., Abe, M, Sakata, R., Okabayashi, H., Hanyu, M., Yamazaki, F., Shimamoto, M., Nishiwaki, N., Imoto, Y., Komiya, T., Horie, M., Fujiwara, H., Mitsudo, K., Nobuyoshi, M., Kita, T., Kimura, T. on Behalf of the CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators (2012) Comparison of Long-Term Outcome after Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting in Patients with Unprotected Left Main Coronary Artery Disease (from the CREDO-Kyoto PCI/CABG Registry Cohort-2). American Journal of Cardiology, 110, 924-932.
http://dx.doi.org/10.1016/j.amjcard.2012.05.022

[25]   Chieffo, A., Meliga, E., Latib, A., Park, S.J., Onuma, Y., Capranzano, P., Valgimigli, M., Jegere, S., Makkar, R.R., Palacios, I.F., Kim, Y.H., Buszman, P.E., Chakravarty, T., Sheiban, I., Mehran, R., Naber, C., Margey, R., Agnihotri, A., Marra, S., Capodanno, D., Leon, M.B., Moses, J.W., Fajadet, J., Lefevre, T., Morice, M.C., Erglis, A., Tamburino, C., Alfieri, O., Serruys, P.W. and Colombo, A. (2012) Drug-Eluting Stent for Left Main Coronary Artery Disease: The DELTA Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting for Left Main Treatment. JACC: Cardiovascular Interventions, 5, 718-727.
http://dx.doi.org/10.1016/j.jcin.2012.03.022

[26]   Buszman, P.E., Buszman, P.P., Kiesz, R.S., Bochenek, A., Trela, B., Konkolewska, M., Bradley, D.W., Wilczynski, M., Szkrobka, I.B., Przybyla, E.P., Krol, M., Kondys, M., Milewski, K., Wiernek, S., Debinski, M., Zurakowski, A.Z., Martin, J.L. and Tendera, M. (2009) Early and Long-Term Results of Unprotected Left Main Coronary Artery Stenting the LE MANS (Left Main Coronary Artery Stenting) Registry. Journal of the American College of Cardiology, 54, 1500-1511. http://dx.doi.org/10.1016/j.jacc.2009.07.007

[27]   Benedetto, U., Melina, G., Angeloni, E., Refice, S., Roscitano, A., Fiorani, B., Di Nucci, G.D. and Sinatra, R. (2009) Coronary Artery Bypass Grafting versus Drug-Eluting Stents in Multivessel Coronary Disease. A Meta-Analysis on 24,268 Patients. European Journal of Cardio-Thoracic Surgery, 36, 611-615.
http://dx.doi.org/10.1016/j.ejcts.2009.03.012

[28]   Bravata, D.M., Gienger, A.L., McDonald, K.M., Sundaram, V., Perez, M.V., Varghese, R., Kapoor, J.R., Ardehali, R., Owens, D.K. and Hlatky, M.A. (2007) Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery. Annals of Internal Medicine, 147, 703-716.
http://dx.doi.org/10.7326/0003-4819-147-10-200711200-00185

[29]   Hoffman, S.N., TenBrook, J.A., Wolf, M.P., Pauker, S.G., Salem, D.N. and Wong, J.B. (2003) A Meta-Analysis of Randomized Controlled Trials Comparing Coronary Artery Bypass Graft with Percutaneous Transluminal Coronary Angioplasty: Oneto Eight-Year Outcomes. Journal of the American College of Cardiology, 41, 1293-1304.
http://dx.doi.org/10.1016/S0735-1097(03)00157-8

[30]   Hlatky, A.A., Boothroyd, D.B., Bravata, D.M., Boersma, E., Booth, J., Brooks, M.M., Carrié, D., Clayton, T.C., Danchin, N., Flather, M., Hamm, C.W., Hueb, W.A., Kähler, J., Kelsey, S.F., King, S.B., Kosinski, A.S., Lopes, N., McDonald, K.M., Rodriguez, A., Serruys, P., Sigwart, U., Stables, R.H., Owens, D.K. and Pocock, S.J. (2009) Coronary Artery Bypass Surgery Compared with Percutaneous Coronary Interventions for Multivessel Disease: A Collaborative Analysis of Individual Patient Data from Ten Randomized Trials. Lancet, 373, 1190-1197.
http://dx.doi.org/10.1016/S0140-6736(09)60552-3

[31]   Sipahi, I., Akay, M.H., Dagdelen, S., Blitz, A. and Alhan, C. (2013) Coronary Artery Bypass Grafting vs. Percutaneous Coronary Intervention and Long-term Mortality and Morbidity in Multivessel Disease Meta-Analysis of Randomized Clinical Trials of the Arterial Grafting and Stenting Era. JAMA Internal Medicine. Published online 2 December.

[32]   Park, S.J. and Park, D.W. (2009) Percutaneous Coronary Intervention with Stent Implantation versus Coronary Artery Bypass Surgery for Treatment of Left Main Coronary Artery Disease: Is It Time to Change Guidelines? Circulation: Cardiovascular Interventions, 2, 59-68. http://dx.doi.org/10.1161/CIRCINTERVENTIONS.108.831701

[33]   de Lezo, J.S., Medina, A., Pan, M., Delgado, A., Segura, J., Pavlovic, D., Melián, F., Romero, M., Burgos, L., Hernández, E., Ureña, I. and Herrador, J. (2004) Rapamycin-Eluting Stents for the Treatment of Unprotected Left Main Coronary, Disease. American Heart Journal, 148, 481-485.
http://dx.doi.org/10.1016/j.ahj.2004.03.011

[34]   Task Force on Myocardial Revascularization of the European Society of Cardiology (2010) Guidelines on Myocardial Revascularization. European Journal of Cardio-Thoracic Surgery, 38, S1-S52.
http://dx.doi.org/10.1016/j.ejcts.2010.08.019

[35]   Steigen, T.K., Maeng, M., Wiseth, R., Erglis, A., Kumsars, I., Narbute, I., et al. (2006) Randomized Study on Simple versus Complex Stenting of Coronary Artery Bifurcation Lesions: The Nordic Bifurcation Study. Circulation, 114, 1955-1961. http://dx.doi.org/10.1161/CIRCULATIONAHA.106.664920

[36]   Al Suwaidi, J., Yeh, W., Cohen, H.A., Detre, K.M., Williams, D.O. and Holmes Jr., D.R. (2001) Immediate and One-Year Outcome in Patients with Coronary Bifurcation Lesions in the Modern Era (NHLBI Dynamic Registry). American Journal of Cardiology, 87, 1139-1144. http://dx.doi.org/10.1016/S0002-9149(01)01482-5

[37]   Yan, B.P., Clark, D.J., Buxton, B., Ajani, A.E., Smith, J.A., Duffy, S.J., Shardey, G.C., Skillington, P.D., Farouque, O., Yii, M., Yap, C.H., Andrianopoulos, N., Brennan, A., Dinhi, D. and Reid, C.M. (2009) Clinical Characteristics and Early Mortality of Patients Undergoing Coronary Artery Bypass Grafting Compared to Percutaneous Coronary Intervention: Insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries. Heart, Lung and Circulation, 18, 184-190. http://dx.doi.org/10.1016/j.hlc.2008.10.005

[38]   Jang, J.S., Choi, K.N., Jin, H.Y., Seo, J.S., Yang, T.H., Kim, D.K., Kim, D.S., Urm, S.H., Chun, J.H., Kang, S.J., Park, D.W., Lee, S.W., Kim, Y.H., Lee, C.W., Park, S.W. and Park, S.J. (2012) Meta-Analysis of Three Randomized Trials and Nine Observational Studies Comparing Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease. American Journal of Cardiology, 110, 1411-1418.
http://dx.doi.org/10.1016/j.amjcard.2012.06.051

[39]   Morice, M.C., Serruys, P.W., Kappetein, A.P., Feldman, T.E., Ståhle, E., Colombo, A., Mack, M.J., Holmes, D.R., Torracca, L., van Es, G.A., Leadley, K., Dawkins, K.D. and Mohr, F. (2010) Outcomes in Patients with de Novo Left Main Disease Treated with either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) Trial. Circulation, 121, 2645-2653. http://dx.doi.org/10.1161/CIRCULATIONAHA.109.899211

[40]   Park, S.J., Kim, Y.H., Park, D.W., Yun, S.C., Ahn, J.M., Song, H.G., Lee, J.Y., Kim, W.J., Kang, S.J., Lee, S.W., Lee, C.W., Park, S.W., Chung, C.H., Lee, J.W., Lim, D.S., Rha, S.W., Lee, S.G., Gwon, H.C., Kim, H.S., Chae, I.H., Jang, Y., Jeong, M.H., Tahk, S.J. and Seung, K.B. (2011) Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease. New England Journal of Medicine, 364, 1718-1727.
http://dx.doi.org/10.1056/NEJMoa1100452

[41]   Jiang, W.B., Zhao, W., Huang, H., Li, C.L., Zhang, J.H., Wang, Y. and Fu, G.S. (2012) Meta-Analysis of Effectiveness of First-Generation Drug-Eluting Stents versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Disease. American Journal of Cardiology, 110, 1764-1772. http://dx.doi.org/10.1016/j.amjcard.2012.08.011

[42]   Capodanno, D., Stone, G.W., Morice, M.C., Bass, T.A. and Tamburino, C. (2011) Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft Surgery in Left Main Coronary Artery Disease: A Meta-Analysis of Randomized Clinical Data. Journal of the American College of Cardiology, 58, 1426-1432.
http://dx.doi.org/10.1016/j.jacc.2011.07.005

[43]   De Luca, G., Schaffer, A., Verdoia, M. and Suryapranata, H. (2013) Meta-Analysis of 14 Trials Comparing Bypass Grafting vs Drug-Eluting Stents in Diabetic Patients with Multivessel Coronary Artery Disease. Nutrition, Metabolism and Cardiovascular Diseases, in Press. http://dx.doi.org/10.1016/j.numecd.2013.11.002

[44]   Niles, N.W., McGrath, P.D., Malenka, D., Quinton, H., Wennberg, D., Shubrooks, S.J., Tryzelaar, J.F., Clough, R., Hearne, M.J., Hernandez Jr., F., Watkins, M.W., O’Connor, G.T. for the Northern New England Cardiovascular Disease Study Group (2001) Survival of Patients with Diabetes and Multivessel Coronary Artery Disease after Surgical or Percutaneous Coronary Revascularization: Results of a Large Regional Prospective Study. Journal of the American College of Cardiology, 37, 1008-1015. http://dx.doi.org/10.1016/S0735-1097(00)01205-5

[45]   Mercado, N., Wijns, W., Serruys, P.W., Sigwart, U., Flather, M.D., Stables, R.H., O’Neill, W.W., Rodriguez, A., Lemos, P.A., Hueb, W.A., Gersh, B.J., Jean Booth, D. and Boersma, E. (2005) One-Year Outcomes of Coronary Artery Bypass Graft Surgery versus Percutaneous Coronary Intervention with Multiple Stenting for Multisystem Disease: A Meta-Analysis of Individual Patient Data from Randomized Clinical Trials. Journal of Thoracic and Cardiovascular Surgery, 130, 512-519. http://dx.doi.org/10.1016/j.jtcvs.2004.12.049

[46]   Brener, S.J., Lytle, B.W., Casserly, I.P., Schneider, J.P., Topol, E.J. and Lauer, M.S. (2004) Propensity Analysis of Long-Term Survival after Surgical or Percutaneous Revascularization in Patients with Multivessel Coronary Artery Disease and High-Risk Features. Circulation, 109, 2290-2295.
http://dx.doi.org/10.1161/01.CIR.0000126826.58526.14

[47]   The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) (2010) Guidelines on Myocardial Revascularization. European Heart Journal, 31, 2501-2555. http://dx.doi.org/10.1093/eurheartj/ehq277

[48]   Fleisher, L.A., Beckman, J.A., Brown, K.A., Calkins, H., Chaikof, E.L., Fleischmann, K.E., Freeman, W.K., Froehlich, J.B., Kasper, E.K., Kersten, J.R., Riegel, B. and Robb, J.F. (2009) ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery. Journal of the American College of Cardiology, 54, e13-e118.
http://dx.doi.org/10.1016/j.jacc.2009.07.010

[49]   Kushner, F.G., Hand, M., Smith Jr., S.C., et al. (2009) Focused Updates: ACC/AHA Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) a Report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 54, 2205-2241.
http://dx.doi.org/10.1016/j.jacc.2009.10.015

[50]   Patel, M.R., Dehmer, G.J., Hirshfeld, J.W., Smith, P.K. and Spertus, J.A. (2009) ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology: Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. Circulation, 119, 1330-1352.
http://dx.doi.org/10.1161/CIRCULATIONAHA.108.191768

[51]   Breeman, A., Hordijk-Trion, M., Lenzen, M, Hoeks, S., Ottervanger, J.P., Bertrand, M.E., Sechtem, U., Zaliunas, R., Legrand, V., de Boer, M.J., Stahle, E., Mercado, N., Wijns, W. and Boersma, E. (2006) Treatment Decisions in Stable Coronary Artery Disease: Insights from the Euro Heart Survey on Coronary Revascularization. Journal of Thoracic and Cardiovascular Surgery, 132, 1001-1009. http://dx.doi.org/10.1016/j.jtcvs.2006.05.051

[52]   Hannan, E.L., Racz, M.J., Gold, J., Cozzens, K., Stamato, N.J., Powell, T., Hibberd, M. and Walford, G. (2010) Adherence of Catheterization Laboratory Cardiologists to American College of Cardiology/American Heart Association Guidelines for Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery: What Happens in Actual Practice? Circulation, 121, 267-275.
http://dx.doi.org/10.1161/CIRCULATIONAHA.109.887539

[53]   Kim, L.J., King III, S.B., Kent, K., Brooks, M.M., Kip, K.E., Abbott, J.D., Jacobs, A.K., Rihal, C., Hueb, W.A., Alderman, E., Pena Sing, I.R., Attubato, M.J. and Feit, F. (2009) Factors Related to the Selection of Surgical versus Percutaneous Revascularization in Diabetic Patients with Multivessel Coronary Artery Disease in the BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes) Trial. JACC: Cardiovascular Interventions, 2, 384-392. http://dx.doi.org/10.1016/j.jcin.2009.01.009

 
 
Top